(Q61917226)
Statements
Phase 1b dose escalation study of erlotinib in combination with infusional 5-Fluorouracil, leucovorin, and oxaliplatin in patients with advanced solid tumors (English)
Jim Cassidy
Javier Sastre
Claus Bolling
Ashok Rakhit
Scott Fettner
Ulrich Brennscheidt
Andrea Feyereislova
Axel-R Hanauske
Robert J Jones
1 January 2007